Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE).
Circ Heart Fail. 2011 Jan 1;4(1):27-35
Authors: Komajda M, Carson PE, Hetzel S, McKelvie R, McMurray J, Ptaszynska A, Zile MR, Demets D, Massie BM
The determinants of prognosis in patients with heart failure and preserved ejection fraction (HF-PEF) are poorly documented.
PMID: 21068341 [PubMed - indexed for MEDLINE]